Compare Tesla, Inc. (TSLA) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tesla, Inc. vs Health Care Select Sector SPDR Fund — how do they compare? Tesla, Inc. trades at $382.7 (market cap $1.48T), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Tesla, Inc. is far larger — about 34× Health Care Select Sector SPDR Fund's market cap, and Health Care Select Sector SPDR Fund is trading nearer its 52-week high, Tesla, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Tesla, Inc. for 88 Days and Health Care Select Sector SPDR Fund for 100 Days on average.
| TSLA | XLV | |
|---|---|---|
Market Cap | $1.48T | $43.48B |
Volume | 28,215,427 | 11,121,431 |
Sector | Consumer Cyclical | — |
52-Week High | $489.88 | $175.68 |
52-Week Low | $298.16 | $141.95 |
Typical Hold Time | 88 Days | 100 Days |
Enterprise Value | $1.45T | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Tesla trades at $375.03, down 0.68% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported Q2 2026 earnings miss ($0.33 actual vs. $0.50 expected) but beat expectations in the previous two quarters. Revenue declined to $94.83B in 2025 with net income margin compressing to 4%. Recent news highlights regulatory approval for driver assistance software in Europe and a potential cheaper EV launch.
Tesla faces near-term headwinds from slowing auto growth and elevated valuations (P/E 347), but long-term optimism centers on autonomous driving and energy segments. Analyst consensus price target of $441.36 suggests 18% upside, though execution risks and competition remain key concerns for investors.
XLV trades at $168.16, down 0.39% with a bearish technical signal from moving averages. The healthcare ETF maintains strong cost advantages with a 0.08% expense ratio compared to peers. Recent news highlights XLV's defensive positioning during market volatility and its historical outperformance during Fed rate hikes. Technical indicators show RSI levels in neutral territory while ADX signals selling pressure.
XLV offers diversified healthcare exposure with competitive expense ratios, positioning it well for defensive investing. Key risks include political uncertainty around healthcare policy and concentrated exposure to domestic S&P 500 stocks. The ETF's low-cost structure and sector diversification provide stability amid market volatility, though technical indicators suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tesla, Inc.
Tesla Inc. designs, manufactures, and sells high-performance electric vehicles and electric vehicle powertrain components. The Company owns its sales and service network and sells electric power train components to other automobile manufacturers. Tesla serves customers worldwide.
Read more on TSLA →About Health Care Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →
